Shopping Cart
Remove All
Your shopping cart is currently empty
TCS 2314 (compound 3) is a potent and selective VLA-4 (α4β1 integrin; CD49d/CD29) antagonist with an IC50 of 4.4 nM. It exhibits high plasma clearance and low oral bioavailability in rats, making it suitable for asthma research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $4,230 | - | In Stock |
| Description | TCS 2314 (compound 3) is a potent and selective VLA-4 (α4β1 integrin; CD49d/CD29) antagonist with an IC50 of 4.4 nM. It exhibits high plasma clearance and low oral bioavailability in rats, making it suitable for asthma research. |
| Targets&IC50 | α4β1:4.4 nM |
| Synonyms | TCS-2314, TCS2314 |
| Molecular Weight | 522.59 |
| Formula | C28H34N4O6 |
| Cas No. | 317353-73-4 |
| Smiles | C(=O)([C@H]1N(C(CC2=CC=C(NC(NC3=C(C)C=CC=C3)=O)C=C2)=O)CCOC1)N4CCC(CC(O)=O)CC4 |
| Relative Density. | 1.325 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.